University of Minnesota. Driven to Discover.
Experts made more recommendations about fractional IPV dosing and also discussed issued related to cholera, Ebola, and diphtheria.
About 4% of patients traveled, a potential target for curbing disease spread.
The phase 2 trials will enroll more than 5,000 adults and kids in Guinea and Liberia.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2020 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.